Aboli Hospital Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.45 Cr
- Company Age 7 Year, 29 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.99 Cr
- Satisfied Charges ₹ 4.10 Cr
- Revenue Growth 81.95%
- Profit Growth -2152.86%
- Ebitda 80.22%
- Net Worth -9.89%
- Total Assets 18.89%
About Aboli Hospital
Aboli Hospital Private Limited (AHPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 January 2018 (Seven years 29 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.45 Cr.
The company currently has active open charges totaling ₹4.99 Cr. The company has closed loans amounting to ₹4.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Kamble and Sarika Kamble serve as directors at the Company.
Company Details
-
Location
Aurangabad, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85320MH2018PTC304240
-
Company No.
304240
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jan 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Aboli Hospital?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Kamble
|
Director | 16-Jan-2018 | Current |
|
Sarika Kamble
|
Director | 16-Jan-2018 | Current |
Financial Performance of Aboli Hospital.
Aboli Hospital Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 81.95% increase. The company also saw a substantial fall in profitability, with a 2152.86% decrease in profit. The company's net worth dipped by a decrease of 9.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aboli Hospital?
In 2021, Aboli Hospital had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Nmdc LimitedAnil Kamble is a mutual person
-
Crossandra Pharma Private LimitedAnil Kamble and Sarika Kamble are mutual person
Charges (Loans)
₹4.99 Cr
₹4.10 Cr
Charges Breakdown by Lending Institutions
- Others : 4.99 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Nov 2023 | Others | ₹4.99 Cr | Open |
| 25 Jan 2019 | Others | ₹4.10 Cr | Satisfied |
How Many Employees Work at Aboli Hospital?
Unlock and access historical data on people associated with Aboli Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aboli Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aboli Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.